Exclusive Sample Report @
https://www.reportsworldwide.com/enquiry?report_id=42612
Major TOC Market:
1 KEY TAKEAWAYS
2
3
4
5
6
7
8
9
DISEASE BACKGROUND
Thyroid cancer subtypes
TREATMENT
Surgery
Radioactive iodine (RAI) therapy
Thyroid hormone therapy
External-beam radiation therapy
Targeted therapy
10 EPIDEMIOLOGY
11 MARKETED DRUGS
12 PIPELINE DRUGS
13 KEY UPCOMING EVENTS
14 LICENSING AND ASSET ACQUISITION DEALS
15 Takeda Adds Exelixis Arrow To Oncology Quiver
16 PARENT PATENTS
17 REVENUE OPPORTUNITY
18 CLINICAL TRIAL LANDSCAPE
19 Sponsors by status
20 Sponsors by phase
21 BIBLIOGRAPHY
22 Prescription information
23 APPENDIX
LIST OF FIGURES
Figure 1: Trends in incident cases of thyroid cancer, 2016–25
Figure 2: Pipeline drugs for thyroid cancer in the US
Figure 3: Pipeline drugs for thyroid cancer, by company
Figure 4: Pipeline drugs for thyroid cancer, by drug type
Figure 5: Pipeline drugs for thyroid cancer, by classifications
Figure 6: Key upcoming events in thyroid cancer
Figure 7: Licensing and asset acquisition deals in thyroid cancer
Figure 8: Parent patents in thyroid cancer
Figure 9: Clinical trials in thyroid cancer
Figure 10: Top 10 drugs for clinical trials in thyroid cancer
Figure 11: Top 10 companies for clinical trials in thyroid cancer
Figure 12: Trial locations in thyroid cancer